Prabhudas Lilladher raises target for Apollo Hospitals stock

Published on 10/08/2026 at 11:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q1 FY27 revenue rose 21.00 percent to INR 70.44 billion. The broker targets Apollo Hospitals stock at INR 10,000.00 after profit rose 34.00 percent.

Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals (ISIN INE437A01024) had its target raised by Prabhudas Lilladher from INR 9,350.00 to INR 10,000.00 on August 14, 2026, according to DSIJ. The revised target followed Apollo Hospitals' Q1 FY27 update and a broker view that the HealthCo restructuring could support the integrated healthcare platform.

Q1 growth supports the target

According to DSIJ on August 14, 2026, consolidated revenue reached INR 70.44 billion in Q1 FY27, up 21.00 percent year on year. The same report said adjusted profit after tax rose 34.00 percent year on year to INR 5.81 billion, while earnings before interest, taxes, depreciation and amortization increased 28.00 percent to INR 10.92 billion.

The comparison is important because the broker's target revision was supported by both operating growth and a valuation case. Prabhudas Lilladher estimated a 25.00 percent annualized growth rate for earnings before interest, taxes, depreciation and amortization between fiscal 2026 and fiscal 2028, while its fiscal 2027 sales estimate rose 1.30 percent to INR 296.66 billion, DSIJ reported.

Restructuring remains the counterweight

The report also identified execution sensitivities. Apollo Hospitals' new hospital units generated losses while the digital business continued to absorb costs, and the proposed restructuring requires regulatory approvals. That leaves the target dependent on the conversion of strong consolidated growth into durable cash generation.

For comparison, the Q1 FY27 report put hospital revenue growth at 22.00 percent year on year and hospital earnings before interest, taxes, depreciation and amortization growth at 20.00 percent. Apollo HealthCo revenue increased 20.00 percent year on year to INR 29.77 billion, while its earnings before interest, taxes, depreciation and amortization rose to INR 1.70 billion from INR 0.94 billion in Q1 FY26, according to DSIJ.

NSE valuation and trading level

Apollo Hospitals traded at INR 7,622.50 on the NSE at 3:05 p.m. IST on October 8, 2026. The quote was inside a 52-week range of INR 6,696.50 to INR 9,070.50, while market capitalization stood at INR 1,096.0 billion.

The NSE listing and the ISIN are assigned to Apollo Hospitals Enterprise Limited by Global Banking and Finance. The combination of a 21.00 percent revenue increase and a 34.00 percent adjusted profit increase gives the INR 10,000.00 target a measurable operating basis, while new-unit losses and restructuring approvals remain the key execution variables.